Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The All of Us Research Program aims to facilitate scientific discovery by providing researchers access to biospecimens stored in its supported Biobank, enabling detailed biomarker analyses that explore associations with chronic diseases. This effort supports activities such as biomarker discovery and validation, disease stratification, and multiomics integration to improve understanding of disease risk, diagnosis, and prognosis, thereby advancing precision medicine. The program's historic goal is to enroll one million participants who contribute data to accelerate research and medical breakthroughs, focusing on how lifestyle, environment, and genetics influence health outcomes. This opportunity is forecasted under grant authorities 42 USC 241 and 284 and is sponsored by the National Institutes of Health within the Department of Health and Human Services. Researchers collaborating through this program will leverage the comprehensive All of Us data resource to enhance the development of individualized prevention, treatment, and care strategies. Key coordination is managed by the All of Us Research Program’s Innovative Collaborations and Ancillary Studies Branch, which can be contacted for further information.

General Info

Provides researchers biospecimen access from 1 million participants for biomarker and disease research.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
Office AddressUS
Contacts
All of Us Research Program Innovative Collaborations and Ancillary Studies Branch

Full Description

Show more

The All of Us Research Program seeks to advance its mission by enabling access to biospecimens stored in the All of Us supported Biobank for researchers to conduct assays to evaluate associations between biomarkers and chronic diseases and add data to the All of Us resource for broad use by researchers. Biomarker analysis includes, but is not limited to, biomarker discovery; biomarker validation; novel disease stratification; and multiomics integration for disease risk, diagnosis, and prognosis, in support of advancing precision medicine. The All of Us Research Program is a historic effort to enroll 1 million participants who share data to accelerate research and medical breakthroughs, and enable individualized prevention, treatment, and care. Researchers use data from the program to learn more about how individual differences in lifestyle, environment, and genetics can influence health and disease.

Grant authorities that allow the All of Us Research Program to forecast this opportunity are as follows: 42 USC 241 and 284.

Similar Contracts

NAICS: 541714
New
Federal
Exosome Purification, Exosomal RNA Purification, and Small RNA-Sequencing ServicesThe National Institutes of Health, in collaboration with the National Institute on Alcohol Abuse and Alcoholism and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, seeks specialized laboratory services to support the POTS clinical research study conducted at NIH in Bethesda, Maryland. The contract requires a qualified provider to process 31 irreplaceable plasma specimens from human participants, performing integrated exosome isolation, exosomal RNA purification, and small RNA-sequencing using Illumina platforms. These tasks must be completed with strict adherence to sample integrity and chain of custody protocols, as the requiring laboratory lacks the validated capacity or bandwidth to perform these procedures in-house within the required timeframe. Each specimen, consisting of 0.5 mL of plasma, must be processed to yield intact exosomes split into multiple aliquots, with exosomal RNA extracted and_QUALITY controlled, and a portion used for downstream sequencing. The contractor is responsible for supplying all personnel, equipment, reagents, and materials necessary to complete the work. The provider must prepare libraries, sequence all 31 samples on the Illumina platform with a target of approximately 20 million raw reads per sample at 1x51 bp, and deliver sequencing data to the government via both physical hard drive and digital download. Basic bioinformatics processing, including read trimming, filtering, and mapping, is also required to ensure analysis-ready outputs. All specimens and resulting materials must be returned to the NIH in accordance with prescribed protocols, maintaining proper documentation and tracking throughout the entire workflow. The solicitation, numbered 75N98026Q00707, is open for response until July 7, 2026, under NAICS code 541714, with no set-aside requirements, and point of contact for inquiries is John Burton at NIH.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
New
Federal
AJ12--Special Notice | Intent to Sole Source | Biostatistics Support for Prostate Cancer Analysis for Treatment Choice (PATCH) Clinical Trials ConsortiumThe Veterans Health Administration, Network Contracting Office 5, intends to award a sole source contract to CANCER RESEARCH & BIOSTATISTICS for biostatistics support services related to the Prostate Cancer Analysis for Treatment Choice (PATCH) Clinical Trials Consortium. The vendor will deliver expert analytical and consulting services to all member institutions of the Precision Oncology Program for Cancer of the Prostate and select sites within the Lung Precision Oncology Program. The work is essential for advancing clinical trial data interpretation and treatment optimization in prostate cancer research within the VA healthcare system. The contract will be issued under FAR Subpart 13.106-1(b), reflecting the government’s determination that only this vendor possesses the unique expertise required to fulfill the requirement. This notice is not a solicitation for competitive bids, but any capable responsible source may submit a capability statement, proposal, or quotation prior to the deadline of July 12, 2026, at 12:00 PM Eastern Time. The government retains full discretion to determine whether to proceed with sole source award based on any submissions received. The action is categorized under NAICS code 541714 for scientific research and development services, and all communications must be directed to Contracting Officer Ethan Mauzy at the Department of Veterans Affairs office in Linthicum, Maryland. The solicitation number is 36C24526Q0624, and details are accessible via the SAM.gov website.
245-NETWORK Contract Office 5 (36C245)

POSTED

4 days ago

DEADLINE

in 12 days
View Details